Drug Profile
Histimex
Latest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator University of Manchester
- Developer Curapel
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Atopic dermatitis
Most Recent Events
- 28 Oct 2019 No recent reports of development identified for phase-I development in Atopic-dermatitis in United Kingdom (PO)